Canada markets open in 7 hours 40 minutes

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.0600+0.0900 (+3.03%)
At close: 04:00PM EDT
3.0600 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 296.69M
Enterprise Value 182.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.44
Price/Book (mrq)3.51
Enterprise Value/Revenue 2.21
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 329.66%
S&P500 52-Week Change 327.84%
52 Week High 34.2700
52 Week Low 31.5400
50-Day Moving Average 32.7919
200-Day Moving Average 32.7729

Share Statistics

Avg Vol (3 month) 3720.14k
Avg Vol (10 day) 3562.16k
Shares Outstanding 596.96M
Implied Shares Outstanding 696.96M
Float 864.31M
% Held by Insiders 127.67%
% Held by Institutions 155.26%
Shares Short (Apr 30, 2024) 46.04M
Short Ratio (Apr 30, 2024) 411.48
Short % of Float (Apr 30, 2024) 48.63%
Short % of Shares Outstanding (Apr 30, 2024) 46.24%
Shares Short (prior month Mar 28, 2024) 44.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -131.95%
Operating Margin (ttm)-87.33%

Management Effectiveness

Return on Assets (ttm)-24.85%
Return on Equity (ttm)-89.90%

Income Statement

Revenue (ttm)82.5M
Revenue Per Share (ttm)0.89
Quarterly Revenue Growth (yoy)172.10%
Gross Profit (ttm)N/A
EBITDA -108.89M
Net Income Avi to Common (ttm)-108.86M
Diluted EPS (ttm)-1.1700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)198.65M
Total Cash Per Share (mrq)2.05
Total Debt (mrq)84.56M
Total Debt/Equity (mrq)99.96%
Current Ratio (mrq)2.56
Book Value Per Share (mrq)0.87

Cash Flow Statement

Operating Cash Flow (ttm)-69.3M
Levered Free Cash Flow (ttm)-20.68M